Cytos Biotechnology appoints Itin as CEO
Cytos Biotechnology, a Swiss biotech company focused on the development of CYT003 in allergic asthma, has appointed Dr. Christian Itin as chief executive officer. The board of directors will propose to the company's shareholders that Itin be elected as member of the board, and it is intended that he will become chairman.
Itin is the former president and CEO of Micromet, a previously Nasdaq-listed biopharmaceutical company, with headquarters in the U.S. and an R&D center in Germany. He led Micromet as CEO from 2004 until its acquisition by Amgen for $1.2 billion in March 2012. In total, Itin has spent 13 years in senior management roles at Micromet. Prior to joining Micromet in 1999, he co-founded Zyomyx, a protein chip company based in Hayward, Calif.